Boston Scientific Corp (NYSE: BSX) Q2 2022 earnings call dated Jul. 27, 2022 Corporate Participants: Lauren Tengler -- Director of Investor Relations Michael F.
Boston Scientific Corp (BSX) Q2 2022 Earnings Call Transcript
Categories
Health Care
MEDS Earnings: Trxade Health Q2 revenues surge 73% amid continued user growth
Trxade Health Inc (NASDAQ: MEDS), a leading health service IT company, reported a sharp increase in its second-quarter 2022 revenues. The top
Petmed Express Inc. (PETS) Q1 2023 Earnings Call Transcript
Petmed Express Inc. (NASDAQ: PETS) Q1 2023 earnings call dated Jul. 25, 2022 Corporate Participants: Bruce S. Rosenbloom -- Chief Financial Officer and Treasurer
TRxADE HEALTH, Inc. (MEDS) Q2 2022 Earnings Call Transcript
TRxADE HEALTH, Inc. (NASDAQ: MEDS) Q2 2022 earnings call dated Jul. 25, 2022 Corporate Participants: Janet Huffman -- Chief Financial Officer Suren Ajjarapu -- Chief Executive
Intuitive Surgical, Inc. (ISRG) Q2 2022 Earnings Call Transcript
Intuitive Surgical, Inc. (NASDAQ: ISRG) Q2 2022 earnings call dated Jul. 21, 2022 Corporate Participants: Brian King -- Treasurer and Head of Investor Relations
Intuitive Surgical Inc. (ISRG) Earnings: 2Q22 Key Numbers
Intuitive Surgical Inc. (NASDAQ: ISRG) reported revenue of $1.52 billion for the second quarter of 2022, up 4% year-over-year. GAAP net income
IQVIA Holdings Inc. (IQV) Q2 2022 Earnings Call Transcript
IQVIA Holdings Inc. (NYSE: IQV) Q2 2022 earnings call dated Jul. 21, 2022 Corporate Participants: Nick Childs -- Senior Vice President, Investor Relations and
Quest Diagnostics Inc. (DGX) Q2 2022 Earnings Call Transcript
Quest Diagnostics Inc. (NYSE: DGX) Q2 2022 earnings call dated Jul. 21, 2022 Corporate Participants: Shawn Bevec -- Vice President of Investor Relations Stephen
Abbott (ABT) Q2 2022 Earnings Call Transcript
Abbott (NYSE: ABT) Q2 2022 earnings call dated Jul. 20, 2022 Corporate Participants: Scott Leinenweber -- Vice President, Investor Relations, Licensing and Acquisitions Robert
Biogen Inc. (BIIB) Q2 2022 Earnings Call Transcript
Biogen Inc. (NASDAQ: BIIB) Q2 2022 earnings call dated Jul. 20, 2022 Corporate Participants: Michael Hencke -- Head of Investor Relations. Michel Vounatsos -- Chief Executive
Anthem, Inc. (ANTM) Q2 2022 Earnings Call Transcript
Anthem, Inc. (NYSE: ANTM) Q2 2022 earnings call dated Jul. 20, 2022 Corporate Participants: Stephen Tanal -- Vice President, Investor Relations Gail K. Boudreaux -- President
Johnson & Johnson (JNJ) Q2 2022 Earnings Call Transcript
Johnson & Johnson (NYSE: JNJ) Q2 2022 earnings call dated Jul. 19, 2022 Corporate Participants: Jessica Moore -- Vice President, Investor Relations Joaquin Duato -- Chief
Novartis AG (NVS) Q2 2022 Earnings Call Transcript
Novartis AG (NYSE: NVS) Q2 2022 earnings call dated Jul. 19, 2022 Corporate Participants: Samir Shah -- Global Head of Investor Relations Vasant (Vas)
Abbott Laboratories (ABT) Earnings: 2Q22 Key Numbers
Abbott Laboratories (NYSE: ABT) reported second quarter 2022 earnings results. Total sales increased 10.1% year-over-year to $11.3 billion. On an organic basis,
Infographic: Key highlights from Biogen (BIIB) Q2 2022 earnings results
Biogen Inc. (NASDAQ: BIIB) reported second quarter 2022 earnings results today. Total revenue decreased 7% year-over-year to $2.58 billion. Net income attributable
UnitedHealth Group Incorporated (UNH) Q2 2022 Earnings Call Transcript
UnitedHealth Group Incorporated (NYSE: UNH) Q2 2022 earnings call dated Jul. 15, 2022 Corporate Participants: Andrew Witty -- Chief Executive Officer Dirk McMahon -- President &
Organigram Holdings Inc. (OGI) Q3 2022 Earnings Call Transcript
Organigram Holdings Inc. (NASDAQ: OGI) Q3 2022 earnings call dated Jul. 14, 2022 Corporate Participants: Craig MacPhail -- Group Director Beena Goldenberg -- Chief Executive Officer
What awaits Johnson & Johnson (JNJ) beyond consumer business spinoff
Johnson & Johnson (NYSE: JNJ) is probably the most diversified healthcare firm that owns several popular consumer brands, which have brought both
Despite generic threat, AbbVie (ABBV) remains a good long-term bet
Biopharmaceutical firm AbbVie Inc. (NYSE: ABBV) is currently at a crucial juncture as it strives to overcome the threat from generic competitors
Angiodynamics Inc (ANGO) Q4 2022 Earnings Call Transcript
Angiodynamics Inc (NASDAQ: ANGO) Q4 2022 earnings call dated Jul. 12, 2022 Corporate Participants: Jim Clemmer -- President and Chief Executive Officer Stephen A.
ANGO Earnings: AngioDynamics swings to profit in Q4; revenues beat estimates
AngioDynamics Inc. (NASDAQ: ANGO) on Tuesday reported a modest profit for the fourth quarter of 2022 compared to breakeven last year. Revenues